171 related articles for article (PubMed ID: 27770210)
1. Characteristics of cases with postoperative vitreous hemorrhage after 25-gauge vitrectomy for repair of proliferative diabetic retinopathy.
Sato T; Tsuboi K; Nakashima H; Emi K
Graefes Arch Clin Exp Ophthalmol; 2017 Apr; 255(4):665-671. PubMed ID: 27770210
[TBL] [Abstract][Full Text] [Related]
2. Vitreous hemorrhage after closed vitrectomy for proliferative diabetic retinopathy.
Tolentino FI; Cajita VN; Gancayco T; Skates S
Ophthalmology; 1989 Oct; 96(10):1495-500. PubMed ID: 2587044
[TBL] [Abstract][Full Text] [Related]
3. Ghost cell glaucoma after intravitreal bevacizumab for postoperative vitreous hemorrhage following vitrectomy for proliferative diabetic retinopathy.
Liu L; Wu WC; Yeung L; Wang NK; Kuo YH; Chao AN; Chen KJ; Chen TL; Lai CC; Hwang YS; Chen YP
Ophthalmic Surg Lasers Imaging; 2010; 41(1):72-7. PubMed ID: 20128573
[TBL] [Abstract][Full Text] [Related]
4. Reasons for and management of postvitrectomy vitreous hemorrhage in proliferative diabetic retinopathy.
Yan H; Cui J; Lu Y; Yu J; Chen S; Xu Y
Curr Eye Res; 2010 Apr; 35(4):308-13. PubMed ID: 20373898
[TBL] [Abstract][Full Text] [Related]
5. Vitreous hemorrhage after the 25-gauge transconjunctival sutureless vitrectomy for proliferative diabetic retinopathy.
Lee BJ; Yu HG
Retina; 2010; 30(10):1671-7. PubMed ID: 21060273
[TBL] [Abstract][Full Text] [Related]
6. Ultra-widefield fluorescein angiographic findings in patients with recurrent vitreous hemorrhage after diabetic vitrectomy.
Kim DY; Kim JG; Kim YJ; Joe SG; Lee JY
Invest Ophthalmol Vis Sci; 2014 Oct; 55(11):7040-6. PubMed ID: 25298415
[TBL] [Abstract][Full Text] [Related]
7. Intraocular VEGF level as a risk factor for postoperative complications after vitrectomy for proliferative diabetic retinopathy.
Wakabayashi Y; Usui Y; Okunuki Y; Ueda S; Kimura K; Muramatsu D; Kezuka T; Goto H
Invest Ophthalmol Vis Sci; 2012 Sep; 53(10):6403-10. PubMed ID: 22899753
[TBL] [Abstract][Full Text] [Related]
8. Risk Factors of Neovascular Glaucoma After 25-gauge Vitrectomy for Proliferative Diabetic Retinopathy with Vitreous Hemorrhage: A Retrospective Multicenter Study.
Takayama K; Someya H; Yokoyama H; Takamura Y; Morioka M; Sameshima S; Ueda T; Kitano S; Tashiro M; Sugimoto M; Kondo M; Sakamoto T; Takeuchi M
Sci Rep; 2019 Oct; 9(1):14858. PubMed ID: 31619708
[TBL] [Abstract][Full Text] [Related]
9. Endodiathermy plus photocoagulation as treatment of sclerotomy site vascularization secondary to pars plana vitrectomy for proliferative diabetic retinopathy.
Nadal J; Carreras E; Canut MI
Retina; 2012 Jul; 32(7):1310-5. PubMed ID: 22466471
[TBL] [Abstract][Full Text] [Related]
10. Role of Tamponade in Vitrectomy for Proliferative Diabetic Retinopathy with Vitreous Hemorrhage.
Balakrishnan D; Jain B; Nayaka A; Rani PK; Mukundaprasad V; Jalali S
Semin Ophthalmol; 2017; 32(4):488-491. PubMed ID: 27128601
[TBL] [Abstract][Full Text] [Related]
11. Fibrovascular ingrowth at sclerotomy sites in vitrectomized diabetic eyes with recurrent vitreous hemorrhage: ultrasound biomicroscopy findings.
Hershberger VS; Augsburger JJ; Hutchins RK; Raymond LA; Krug S
Ophthalmology; 2004 Jun; 111(6):1215-21. PubMed ID: 15177974
[TBL] [Abstract][Full Text] [Related]
12. Outcomes of 25-gauge pars plana vitrectomy in the surgical management of proliferative diabetic retinopathy.
Schoenberger SD; Miller DM; Riemann CD; Foster RE; Sisk RA; Hutchins RK; Petersen MR
Ophthalmic Surg Lasers Imaging; 2011; 42(6):474-80. PubMed ID: 21902167
[TBL] [Abstract][Full Text] [Related]
13. Postoperative vitreous hemorrhage after diabetic 23-gauge pars plana vitrectomy.
Khuthaila MK; Hsu J; Chiang A; DeCroos FC; Milder EA; Setlur V; Garg SJ; Spirn MJ
Am J Ophthalmol; 2013 Apr; 155(4):757-63, 763.e1-2. PubMed ID: 23317651
[TBL] [Abstract][Full Text] [Related]
14. Comparison of microinsicion vitrectomy and conventional 20-gauge vitrectomy for severe proliferative diabetic retinopathy.
Yokota R; Inoue M; Itoh Y; Rii T; Hirota K; Hirakata A
Jpn J Ophthalmol; 2015 Sep; 59(5):288-94. PubMed ID: 26202442
[TBL] [Abstract][Full Text] [Related]
15. Outcomes and complications of 25-gauge transconjunctival sutureless vitrectomy for proliferative diabetic retinopathy.
Ozone D; Hirano Y; Ueda J; Yasukawa T; Yoshida M; Ogura Y
Ophthalmologica; 2011; 226(2):76-80. PubMed ID: 21613797
[TBL] [Abstract][Full Text] [Related]
16. Visual outcomes and incidence of recurrent vitreous hemorrhage after vitrectomy in diabetic eyes pretreated with bevacizumab (avastin).
Lo WR; Kim SJ; Aaberg TM; Bergstrom C; Srivastava SK; Yan J; Martin DF; Hubbard GB
Retina; 2009; 29(7):926-31. PubMed ID: 19584650
[TBL] [Abstract][Full Text] [Related]
17. Intravitreal long-acting gas in the prevention of early postoperative vitreous hemorrhage in diabetic vitrectomy.
Yang CM; Yeh PT; Yang CH
Ophthalmology; 2007 Apr; 114(4):710-5. PubMed ID: 17275908
[TBL] [Abstract][Full Text] [Related]
18. Bevacizumab pretreatment and long-acting gas infusion on vitreous clear-up after diabetic vitrectomy.
Yang CM; Yeh PT; Yang CH; Chen MS
Am J Ophthalmol; 2008 Aug; 146(2):211-217. PubMed ID: 18547539
[TBL] [Abstract][Full Text] [Related]
19. Combined 23-gauge sutureless vitrectomy and clear corneal phacoemulsification in patients with proliferative diabetic retinopathy.
Lee DY; Jeong HS; Sohn HJ; Nam DH
Retina; 2011 Oct; 31(9):1753-8. PubMed ID: 21555968
[TBL] [Abstract][Full Text] [Related]
20. [Different outcome among eyes with proliferative diabetic retinopathy indicated for vitrectomy].
Muramatsu M; Yokoi M; Muramatsu A; Saito W; Furudate N; Ohno S
Nippon Ganka Gakkai Zasshi; 2006 Dec; 110(12):950-60. PubMed ID: 17228758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
